Diagnostics for resource-limited settings in the era of interferon-free HCV therapy

Journal of Viral Hepatitis

Volumn 22, Issue 5, 2015, Pages 459-460

  Cooke, G S ^a   Hill, A M ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

diagnostics; HCV; HIV HCV

Indexed keywords

ANTIVIRUS AGENT; INTERFERON;

AFRICA SOUTH OF THE SAHARA; ANTIGEN DETECTION; ANTIVIRAL THERAPY; DIAGNOSTIC VALUE; DRUG APPROVAL; DRUG TREATMENT FAILURE; EUROPE; FALSE POSITIVE RESULT; GENOTYPE; HEALTH CARE UTILIZATION; HEPATITIS C; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR DIAGNOSIS; NUCLEIC ACID ANALYSIS; PATIENT CARE; PATIENT MONITORING; POINT OF CARE TESTING; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; SEROLOGY; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; VIRUS LOAD; DEVELOPING COUNTRY; DIAGNOSTIC TEST; HOSPITAL INFORMATION SYSTEM; PROCEDURES;

ANTIVIRAL AGENTS; DEVELOPING COUNTRIES; DIAGNOSTIC TESTS, ROUTINE; EUROPE; HEPATITIS C; HUMANS; POINT-OF-CARE SYSTEMS; UNITED STATES;

EID: 84926513721     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12401     Document Type: Review

References (9)

1. Ford N, Kirby C, Singh K, et al,. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ 2012; 90 (7): 540-550.
2. Davies A, Singh KP, Shubber Z, et al,. Treatment outcomes of treatment-naive Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts. PLoS ONE 2012; 8 (2): e55373.
3. Hill A, Cooke G,. Medicine. Hepatitis C can be cured globally, but at what cost? Science 2014; 345 (6193): 141-142.
4. King S, Adjei-Asante K, Appiah L, et al,. Antibody tests variably overestimate the prevalence of hepatitis C virus (HCV) infection among HIV-infected adults in Ghana. J Viral Hepatitis 2014. doi: 10.1111/jvh.12354. [Epub ahead of print].
5. Messina JP, Humphreys I, Flaxman A, et al,. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2014; 61: 77-87.
6. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST,. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57 (4): 1333-1342.
7. Madhava V, Burgess C, Drucker E,. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2 (5): 293-302.
8. Razavi H, Estes C, Hindman S, Razavi-Shearer K, Gower E,. The Global Burden of viremic HCV infection. Hepatology (Supp) 2014; 60: 1488.
9. Ford N, Singh K, Cooke GS, et al,. Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis 2012; 54 (10): 1465-1472.